Insider selling is consistent across multiple insiders but modest relative to market cap, the selling is likely not a material signal of deterioration. Monitor for any negative pipeline updates or upcoming financing events.
IMNM drugs
IMNM drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 6 $23.61entry
- T+1 · 4mo ago +1.23%α +0.36% · $23.90
- T+5 · 4mo ago +2.37%α +1.44% · $24.17
- T+20 · 4mo ago −2.24%α −1.83% · $23.08
- T+60 · 7w ago −8.17%α −11.74% · $21.68
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director Isaac Barchas and CMO Robert Lechleider sold a combined $2.93M in open-market sales over a week, with Barchas alone accounting for $2.13M. The cluster is entirely selling, and the total value (~0.12% of $2.4B market cap) is modest. Historical insider activity shows $6.6M in selling over 30 days, continuing this pattern.
Key Financial Metrics
Key Facts
- Director Barchas sold 76k shares at $22.35 on 7/2, 24k at $23.33 on 7/2, and 101k at $21.12 on 6/30; total Barchas sales = $4.39M across the cluster window
- CMO Lechleider sold 41k shares at $19.56 for $794k
- Cluster total: $2.93M in open-market sales; prior-30d insider selling totaled $6.6M
- No insider buying in the cluster, net direction is selling
- Market cap is $2.4B; cluster value is ~0.12% of market cap, below the 0.5% materiality threshold for outsized significance
Financial Impact
Total insider sales of $2.93M in this cluster (~0.12% of market cap), with $4.39M from the director alone.
Risk Factors
- Continued insider selling without buying could signal unstated concerns
- Biotech sector: any pipeline setback would compound selling pressure
- Historical stock drift has been negative after most filings; the pattern is bearish
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-IMNM-1783038756017 |
Track record
20 reports on IMNM
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $18.39 Now $17.61 −4.24% settles Feb 12
- Nov 9, 20267d ago S-3ASR Neutral 3/10 Entry $18.65 Now $17.61 −5.58% settles Feb 8
- Nov 9, 20267d ago S-3ASR Neutral 3/10 Entry $18.65 Now $17.61 −5.58% settles Feb 8
- Nov 9, 20267d ago 8-K Bearish 5/10 Entry $18.65 Now $17.61 +5.58% settles Feb 8
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $18.21 Now $17.61 −3.29% settles Jan 28
- Oct 16, 20264w ago ANALYST-UPGRADE Bullish 4/10 Entry $16.47 Now $17.61 +6.92% settles Jan 13
- Oct 5, 20266w ago 8-K Bullish 6/10 Entry $21.17 Now $17.61 −16.82% settles Dec 30
- Oct 1, 20266w ago ANALYST-UPGRADE Bearish 4/10 Entry $20.89 Now $17.61 +15.70% settles Dec 28
- Sep 21, 20268w ago ANALYST-UPGRADE Bullish 4/10 Entry $25.07 Now $17.61 −29.76% settles Dec 15
- Aug 12, 202613w ago Insider Cluster Neutral 4/10 Entry $26.42 to $18.71 Now $17.61 −33.35% ▼ −29.18% −23.71% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers